Department of Anesthesiology Archive — Page 4 of 15

Colorful illustration of overlapping cyan and magenta human head profiles filled with gears, clockwork, and a large clock face.
March 2, 2023

Sex counts in the brain as seasons change

Photoperiod, or length of day, has sex-specific impacts on dopamine dynamics in the brain, offering insights into sex differences in neuropsychiatric disorders, Vanderbilt researchers report.

gloved hand handling sterile surgical tools
December 14, 2022

Surgical risk persists for patients who’ve had COVID

Vanderbilt researchers report that the trend of decreasing postoperative risk for people who have had COVID persists longer than previously known, for as long as 13 months after COVID.

The study team included, from left, David McIlroy, MD, Matthew Shotwell, PhD, Cassandra Hennessy, MS, and Frederic (Josh) Billings IV, MD. (photo by Donn Jones)
November 30, 2022

Study links excess oxygen during anesthesia to risk of organ injury

A Vanderbilt study found that higher levels of excess oxygen given to patients under general anesthesia add risk of injury to the kidneys, lungs and heart.

3D histological illustration of a row of tall columnar epithelial cells, with elongated nuclei and a brush-like apical surface above a purple underlying layer.
November 7, 2022

Gene mutations impair gut barrier

Mutations in a cell membrane transporter protein impair the integrity of the gut lining, contributing to chronic gastrointestinal distress for people with the mutations, Vanderbilt researchers report.

Blue glowing stylized brain against a black background.
November 3, 2022

Social behavior brain circuitry

Vanderbilt researchers have identified a novel mechanism regulating social behavior: Neuropeptide Y signaling in the nucleus accumbens brain region.

Eric Delpire stands with his arms crossed in a laboratory, beside a microscope and shelves of bottles and equipment.
November 3, 2022

Study explores possible drug target for neurological problems

A team at Case Western Reserve University and Vanderbilt University Medical Center has determined with atomic-level precision how two established drugs bind to and alter the conformation of a cell membrane transporter protein called NKCC1, shutting down its activity.